162 related articles for article (PubMed ID: 34413653)
1. Organization, Clinical and Management Indicators on the First Year of Activity of an Outpatient Clinic Dedicated to the Diagnosis and Treatment of Severe Asthma in Italy.
Tognella S; Micheletto C; Roggeri A; Polese G; Artioli D; Senna G; Caminati M; Roggeri DP
J Asthma Allergy; 2021; 14():1011-1018. PubMed ID: 34413653
[TBL] [Abstract][Full Text] [Related]
2. Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities.
Crimi C; Campisi R; Cacopardo G; Intravaia R; Nolasco S; Porto M; Pelaia C; Crimi N
World Allergy Organ J; 2020 Sep; 13(9):100462. PubMed ID: 32994855
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Allergic, Eosinophilic, and Overlapping Asthma Phenotypes Among Pediatric Patients with Current Asthma: A Cross-Sectional Study from Saudi Arabia.
Asseri AA
J Asthma Allergy; 2023; 16():1297-1308. PubMed ID: 38058515
[TBL] [Abstract][Full Text] [Related]
4. Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis.
Canonica GW; Blasi F; Crimi N; Paggiaro P; Papi A; Fanelli F; Stassaldi A; Furneri G
Clin Mol Allergy; 2021 May; 19(1):5. PubMed ID: 34020658
[TBL] [Abstract][Full Text] [Related]
5. PRevalence of the Eosinophilic Phenotype Among SeveRE asthma patients in Lebanon: results of the PREPARE study.
Abi Saleh W; Alameh Z; Aoun Bacha Z; Bahous J; Bou Khalil P; Chahine Z; Chami H; Dabar G; Dheiny H; Dib A; Farhat D; Irani C; Juvelekian G; Kanj N; Mansour B; Riachi M; Waked M; Yassine M; Youakim C; Zeinedine S; Zaitoun F
Allergy Asthma Clin Immunol; 2023 Sep; 19(1):80. PubMed ID: 37684679
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effects of Benralizumab Assessed in Patients with Severe Eosinophilic Asthma: Real-Life Evaluation Correlated with Allergic and Non-Allergic Phenotype Expression.
Pelaia C; Crimi C; Benfante A; Caiaffa MF; Calabrese C; Carpagnano GE; Ciotta D; D'Amato M; Macchia L; Nolasco S; Pelaia G; Pellegrino S; Scichilone N; Scioscia G; Spadaro G; Valenti G; Vatrella A; Crimi N
J Asthma Allergy; 2021; 14():163-173. PubMed ID: 33654413
[TBL] [Abstract][Full Text] [Related]
7. Switching from omalizumab to mepolizumab: real-life experience from Southern Italy.
Carpagnano GE; Pelaia C; D'Amato M; Crimi N; Scichilone N; Scioscia G; Resta O; Calabrese C; Pelaia G; Quarato CMI; Foschino Barbaro MP
Ther Adv Respir Dis; 2020; 14():1753466620929231. PubMed ID: 32482128
[TBL] [Abstract][Full Text] [Related]
8. Clinical Recommendations for the Management of Biological Treatments in Severe Asthma Patients: A Consensus Statement.
Delgado J; Dávila IJ; Domínguez-Ortega J;
J Investig Allergol Clin Immunol; 2021 Feb; 31(1):36-43. PubMed ID: 32856593
[TBL] [Abstract][Full Text] [Related]
9. Primary care of asthma: new options for severe eosinophilic asthma.
Skolnik NS; Carnahan SP
Curr Med Res Opin; 2019 Jul; 35(7):1309-1318. PubMed ID: 30880484
[No Abstract] [Full Text] [Related]
10. Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry.
Canonica GW; Malvezzi L; Blasi F; Paggiaro P; Mantero M; Senna G; Heffler E;
Respir Med; 2020 May; 166():105947. PubMed ID: 32250875
[TBL] [Abstract][Full Text] [Related]
11. Biologics and Bronchial Thermoplasty for severe refractory asthma treatment: From eligibility criteria to real practice. A cross-sectional study.
Menzella F; Galeone C; Ruggiero P; Bagnasco D; Catellani C; Facciolongo N
Pulm Pharmacol Ther; 2020 Feb; 60():101874. PubMed ID: 31857207
[TBL] [Abstract][Full Text] [Related]
12. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort.
Heaney LG; Perez de Llano L; Al-Ahmad M; Backer V; Busby J; Canonica GW; Christoff GC; Cosio BG; FitzGerald JM; Heffler E; Iwanaga T; Jackson DJ; Menzies-Gow AN; Papadopoulos NG; Papaioannou AI; Pfeffer PE; Popov TA; Porsbjerg CM; Rhee CK; Sadatsafavi M; Tohda Y; Wang E; Wechsler ME; Alacqua M; Altraja A; Bjermer L; Björnsdóttir US; Bourdin A; Brusselle GG; Buhl R; Costello RW; Hew M; Koh MS; Lehmann S; Lehtimäki L; Peters M; Taillé C; Taube C; Tran TN; Zangrilli J; Bulathsinhala L; Carter VA; Chaudhry I; Eleangovan N; Hosseini N; Kerkhof M; Murray RB; Price CA; Price DB
Chest; 2021 Sep; 160(3):814-830. PubMed ID: 33887242
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of eosinophilic, atopic, and overlap phenotypes among patients with severe asthma in Saudi Arabia: a cross-sectional study.
Al-Jahdali H; Wali S; Albanna AS; Allehebi R; Al-Matar H; Fattouh M; Beekman M
BMC Pulm Med; 2022 Feb; 22(1):67. PubMed ID: 35177038
[TBL] [Abstract][Full Text] [Related]
14. RItA: The Italian severe/uncontrolled asthma registry.
Maio S; Baldacci S; Bresciani M; Simoni M; Latorre M; Murgia N; Spinozzi F; Braschi M; Antonicelli L; Brunetto B; Iacovacci P; Roazzi P; Pini C; Pata M; La Grasta L; Paggiaro P; Viegi G;
Allergy; 2018 Mar; 73(3):683-695. PubMed ID: 29072882
[TBL] [Abstract][Full Text] [Related]
15. Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate-to-severe asthma.
Chen M; Shepard K; Yang M; Raut P; Pazwash H; Holweg CTJ; Choo E
Clin Exp Allergy; 2021 Apr; 51(4):546-555. PubMed ID: 33217063
[TBL] [Abstract][Full Text] [Related]
16. Switch from Omalizumab to Benralizumab in Allergic Patients with Severe Eosinophilic Asthma: A Real-Life Experience from Southern Italy.
Pelaia C; Crimi C; Nolasco S; Carpagnano GE; Brancaccio R; Buonamico E; Campisi R; Gagliani C; Patella V; Pelaia G; Valenti G; Crimi N
Biomedicines; 2021 Dec; 9(12):. PubMed ID: 34944638
[TBL] [Abstract][Full Text] [Related]
17. Quality improvement project to increase screening and referral for biologic therapy for patients with uncontrolled asthma.
Davis P; Edie AH; Rushton S; Cleven K
J Asthma; 2022 Dec; 59(12):2386-2394. PubMed ID: 34929114
[TBL] [Abstract][Full Text] [Related]
18. The Severe Asthma Network in Italy: Findings and Perspectives.
Heffler E; Blasi F; Latorre M; Menzella F; Paggiaro P; Pelaia G; Senna G; Canonica GW;
J Allergy Clin Immunol Pract; 2019; 7(5):1462-1468. PubMed ID: 30368004
[TBL] [Abstract][Full Text] [Related]
19. Management of patients with severe asthma: results from a survey among allergists and clinical immunologists of the Central Italy Inter-Regional Section of SIAAIC.
Carli G; Farsi A; Bormioli S; Ridolo E; Fassio F; Pucci S; Montevecchi M; Riparbelli M; Cosmi L; Parronchi P; Rossi O
Clin Mol Allergy; 2021 Dec; 19(1):22. PubMed ID: 34872572
[TBL] [Abstract][Full Text] [Related]
20. Real-life evaluation of mepolizumab efficacy in patients with severe eosinophilic asthma, according to atopic trait and allergic phenotype.
Pelaia C; Crimi C; Pelaia G; Nolasco S; Campisi R; Heffler E; Valenti G; Crimi N
Clin Exp Allergy; 2020 Jul; 50(7):780-788. PubMed ID: 32347992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
